Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Merck Frosst synthesizes potent, selective and orally active PDE4 inhibitors

Dec. 18, 2000

Two series of inhibitors of alpha4beta1-mediated cell adhesion claimed by Aventis

Dec. 18, 2000

Inhibitors of Lp-PLA2 and their use in atherosclerosis described by SB in recent patent

Dec. 18, 2000

Large group of MEK-inhibitory quinolines discovered at AstraZeneca

Dec. 18, 2000

More PARP inhibitors identified at BASF

Dec. 15, 2000

Recent patent covers selective COX-2 inhibitors synthesized at Merck Frosst

Dec. 15, 2000

Potential new contraceptive agents patented by Schering

Dec. 15, 2000

Novel Aventis compounds for cardiovascular disorders interact with angiotensin receptors

Dec. 15, 2000

New progesterone receptor modulators continue to emerge from AHP/Ligand alliance

Dec. 15, 2000

Roche presents new antitumor agents acting on cyclin-dependent kinases

Dec. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...